JP6301909B2 - ストレッチバルブバルーンカテーテルならびにその製造および使用方法 - Google Patents
ストレッチバルブバルーンカテーテルならびにその製造および使用方法 Download PDFInfo
- Publication number
- JP6301909B2 JP6301909B2 JP2015509096A JP2015509096A JP6301909B2 JP 6301909 B2 JP6301909 B2 JP 6301909B2 JP 2015509096 A JP2015509096 A JP 2015509096A JP 2015509096 A JP2015509096 A JP 2015509096A JP 6301909 B2 JP6301909 B2 JP 6301909B2
- Authority
- JP
- Japan
- Prior art keywords
- balloon
- lumen
- inflation
- catheter
- proximal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004519 manufacturing process Methods 0.000 title description 5
- 239000012530 fluid Substances 0.000 claims description 216
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 description 70
- 210000003708 urethra Anatomy 0.000 description 69
- 230000008602 contraction Effects 0.000 description 68
- 230000006378 damage Effects 0.000 description 58
- 238000000034 method Methods 0.000 description 52
- 229920000126 latex Polymers 0.000 description 51
- 239000004816 latex Substances 0.000 description 50
- 230000002485 urinary effect Effects 0.000 description 37
- 230000007246 mechanism Effects 0.000 description 30
- 239000007788 liquid Substances 0.000 description 27
- 239000000853 adhesive Substances 0.000 description 23
- 230000001070 adhesive effect Effects 0.000 description 23
- 230000008569 process Effects 0.000 description 23
- 238000001125 extrusion Methods 0.000 description 22
- 230000007704 transition Effects 0.000 description 20
- 208000014674 injury Diseases 0.000 description 13
- 238000007789 sealing Methods 0.000 description 13
- 238000001356 surgical procedure Methods 0.000 description 13
- 210000002700 urine Anatomy 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 238000004891 communication Methods 0.000 description 12
- 230000000670 limiting effect Effects 0.000 description 10
- 229920001971 elastomer Polymers 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 230000002028 premature Effects 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 7
- 230000010339 dilation Effects 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000005060 rubber Substances 0.000 description 6
- 208000031481 Pathologic Constriction Diseases 0.000 description 5
- 210000002307 prostate Anatomy 0.000 description 5
- 230000036262 stenosis Effects 0.000 description 5
- 208000037804 stenosis Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000000916 dilatatory effect Effects 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 239000011295 pitch Substances 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 208000034693 Laceration Diseases 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 238000002399 angioplasty Methods 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000000642 iatrogenic effect Effects 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000000071 blow moulding Methods 0.000 description 2
- 239000007767 bonding agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 201000003146 cystitis Diseases 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000009528 severe injury Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 208000033999 Device damage Diseases 0.000 description 1
- 206010061213 Iatrogenic injury Diseases 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000034906 Medical device complication Diseases 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010046461 Urethral pain Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000007915 intraurethral administration Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229940020573 plavix Drugs 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 208000037974 severe injury Diseases 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229920006132 styrene block copolymer Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920006344 thermoplastic copolyester Polymers 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 229920006345 thermoplastic polyamide Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261637690P | 2012-04-24 | 2012-04-24 | |
| US61/637,690 | 2012-04-24 | ||
| US13/707,752 US8591497B2 (en) | 2006-01-25 | 2012-12-07 | Stretch valve balloon catheter and methods for producing and using same |
| US13/707,752 | 2012-12-07 | ||
| US13/862,163 US9056192B2 (en) | 2006-01-25 | 2013-04-12 | Stretch valve balloon catheter and methods for producing and using same |
| US13/862,163 | 2013-04-12 | ||
| US13/868,376 US9586022B2 (en) | 2006-01-25 | 2013-04-23 | Stretch valve balloon catheter and methods for producing and using same |
| US13/868,376 | 2013-04-23 | ||
| PCT/US2013/037909 WO2013163254A1 (en) | 2012-04-24 | 2013-04-24 | Stretch valve balloon catheter and methods for producing and using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015519106A JP2015519106A (ja) | 2015-07-09 |
| JP2015519106A5 JP2015519106A5 (enExample) | 2016-11-24 |
| JP6301909B2 true JP6301909B2 (ja) | 2018-03-28 |
Family
ID=53838098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015509096A Active JP6301909B2 (ja) | 2012-04-24 | 2013-04-24 | ストレッチバルブバルーンカテーテルならびにその製造および使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6301909B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210052876A1 (en) * | 2019-08-23 | 2021-02-25 | Becton, Dickinson And Company | Device set designed for pcnl surgery |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11583664B2 (en) * | 2019-11-07 | 2023-02-21 | Stryker Corporation | Balloon catheter assembly for insertion and positioning therapeutic devices within a vascular system |
| US11918282B2 (en) * | 2020-04-17 | 2024-03-05 | Biosense Webster (Israel) Ltd. | Pressure relief feature for irrigated RF balloon catheter |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060062B2 (en) * | 2003-06-04 | 2006-06-13 | Cryo Vascular Systems, Inc. | Controllable pressure cryogenic balloon treatment system and method |
| US7662145B2 (en) * | 2003-09-17 | 2010-02-16 | Prostalund Operations Ab | Partial-length indwelling urinary catheter and method permitting selective urine discharge |
| US8382708B2 (en) * | 2005-01-26 | 2013-02-26 | Mayser, Llc | Zero-pressure balloon catheter and method for using the catheter |
| US7883503B2 (en) * | 2005-01-26 | 2011-02-08 | Kalser Gary | Illuminating balloon catheter and method for using the catheter |
| JP2006333888A (ja) * | 2005-05-31 | 2006-12-14 | Sekisui Chem Co Ltd | バルーンカテーテル |
| JP5353100B2 (ja) * | 2008-07-25 | 2013-11-27 | 株式会社カネカ | バルーンカテーテル |
| US8500684B2 (en) * | 2009-09-18 | 2013-08-06 | Bruce A. Gardner | Balloon catheter |
-
2013
- 2013-04-24 JP JP2015509096A patent/JP6301909B2/ja active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210052876A1 (en) * | 2019-08-23 | 2021-02-25 | Becton, Dickinson And Company | Device set designed for pcnl surgery |
| US12109382B2 (en) * | 2019-08-23 | 2024-10-08 | Becton, Dickinson And Company | Device set designed for PCNL surgery |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015519106A (ja) | 2015-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9044571B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US9572954B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| AU2022275527B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| WO2013163254A1 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US12201794B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US9056192B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| JP6301950B2 (ja) | ストレッチバルブバルーンカテーテルならびにその製造方法および使用方法 | |
| JP6301909B2 (ja) | ストレッチバルブバルーンカテーテルならびにその製造および使用方法 | |
| US9586022B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US8591497B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US20190151632A1 (en) | Stretch Valve Balloon Catheter and Methods for Producing and Using Same | |
| US9878124B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| US9642992B2 (en) | Stretch valve balloon catheter and methods for producing and using same | |
| CA2813919C (en) | Stretch valve balloon catheter and methods for producing and using same | |
| CA2839061C (en) | Stretch valve balloon catheter and methods for producing and using same | |
| AU2013205073B2 (en) | Stretch valve balloon catheter and methods for producing and using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20160418 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161005 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20170224 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170307 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20170606 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170801 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180130 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180301 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6301909 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |